Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Staphylococcus Aureus (S. Aureus or “staph”)
  4. Vancomycin Intermediate Staphylococcus Aureus (VISA) and Vancomycin Resistant Staphylococcus Aureus (VRSA)
Topic Menu

VISA and VRSA

  • VISA/VRSA Home
  • VISA/VRSA For Health Professionals

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources

VISA and VRSA

  • VISA/VRSA Home
  • VISA/VRSA For Health Professionals

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Vancomycin Intermediate Staphylococcus aureus (VISA) 
and Vancomycin Resistant Staphylococcus aureus (VRSA)

There have been several reports of Staphylococcus aureus (S. aureus) bacteria that are resistant to the antibiotic vancomycin. Vancomycin is an antibiotic to which most S. aureus bacteria are susceptible and is used to treat many serious bacterial infections that are resistant to other antibiotics.

To date, all vancomycin resistant Staphylococcus aureus (VRSA) bacteria have been susceptible to other antibiotics.

  • CDC: VISA/VRSA - Vancomycin-Intermediate/Resistant Staphylococcus aureus
    VISA and VRSA fact sheet from the CDC. 
     
  • As VISA and VRSA are types of Staphylococcus aureus infection. The transmission, signs and symptoms of infection, duration of illness, complications and diagnosis are the same as for Staphylococcus aureus.
    • Causes and Symptoms of Staphylococcus aureus
      Staphylococcus aureus facts, including how S. aureus is spread, common symptoms and complications.
  • VISA and VRSA Information for Health Professionals 
    Information for laboratories, clinical features, references, and required reporting information.

see also>> Staphylococcus aureus

Tags
  • staph
Last Updated: 05/21/2024

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube